Correlation Between Centessa Pharmaceuticals and Inventiva
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Inventiva at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Inventiva into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Inventiva Sa, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Inventiva and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Inventiva. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Inventiva.
Diversification Opportunities for Centessa Pharmaceuticals and Inventiva
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Centessa and Inventiva is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Inventiva Sa in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inventiva Sa and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Inventiva. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inventiva Sa has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Inventiva go up and down completely randomly.
Pair Corralation between Centessa Pharmaceuticals and Inventiva
Given the investment horizon of 90 days Centessa Pharmaceuticals is expected to generate 1.02 times less return on investment than Inventiva. But when comparing it to its historical volatility, Centessa Pharmaceuticals PLC is 1.7 times less risky than Inventiva. It trades about 0.11 of its potential returns per unit of risk. Inventiva Sa is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 224.00 in Inventiva Sa on September 11, 2024 and sell it today you would earn a total of 35.00 from holding Inventiva Sa or generate 15.62% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Centessa Pharmaceuticals PLC vs. Inventiva Sa
Performance |
Timeline |
Centessa Pharmaceuticals |
Inventiva Sa |
Centessa Pharmaceuticals and Inventiva Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Centessa Pharmaceuticals and Inventiva
The main advantage of trading using opposite Centessa Pharmaceuticals and Inventiva positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Inventiva can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inventiva will offset losses from the drop in Inventiva's long position.The idea behind Centessa Pharmaceuticals PLC and Inventiva Sa pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Inventiva vs. Mineralys Therapeutics, Common | Inventiva vs. Eliem Therapeutics | Inventiva vs. Anebulo Pharmaceuticals | Inventiva vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |